BMY vs JRSH · P/E 17, rev $24.46B vs rev $166.3M
Bristol-Myers Squibb Company (BMY) versus Jerash Holdings US Inc (JRSH) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Jerash Holdings US Inc (JRSH) is a apparel manufacturing company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported JRSH revenue for 2026-03-31 was $166.3M. Net income was $3.5M. Revenue was up 14.0% from 2025-03-31 to 2026-03-31. JRSH currently screens at market cap $42.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. JRSH currently screens at market cap $42.1M.
Not investment advice. Open the BMY and JRSH stock pages for the full models.
Not investment advice.